The specific attributes of inhaler devices can influence patient use, satisfaction and treatment compliance, and may ultimately impact on clinical outcomes in patients with chronic obstructive ...

AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation by the European Commission (EC) to be used as a ...

Duaklir Genuair is a fixed-dose combination of Eklira, a long-acting muscarinic-antagonist, and Mylan, Inc.’s (MYL) Perforomist (formoterol fumarate), a long-acting beta-agonist. Both are individually ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BRIMICA GENUAIR 340/12 contains the active ingredient aclidinium ...

MISSISSAUGA, ON, Oct. 31, 2013 /CNW/ - Almirall Canada announced the Health Canada approval of Tudorza™ Genuair™ (aclidinium bromide) as a long-term maintenance bronchodilator treatment in patients ...

Barcelona, September, 25 2014. - Almirall S.A. (ALM) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion ...

AstraZeneca's (AZ) Duaklir Genuair (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation (MA) by the European Commission (EC) for use as a maintenance ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BRETARIS GENUAIR contains the active ingredient aclidinium bromide.

AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation by the European Commission (EC) to be used as a ...

MISSISSAUGA, ON, Oct. 29, 2015 /CNW/ - AstraZeneca Canada announced today that DUAKLIR ™ GENUAIR ® (aclidinium bromide/formoterol fumarate dihydrate 400/12 μg) is now available in Canada for the ...